Cargando…
Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer due to a fast tumor doubling time and early hematogenous spread. Advances in the treatment of non-small cell lung cancer using targeted therapies having been made, but no targeted drugs for SCLC have been approved. The Wnt sign...
Autores principales: | Guo, Wenxuan, Shen, Fangzhen, Xiao, Wenjing, Chen, Jing, Pan, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754901/ https://www.ncbi.nlm.nih.gov/pubmed/29344117 http://dx.doi.org/10.3892/ol.2017.7100 |
Ejemplares similares
-
Bioactivity Studies of Hesperidin and XAV939
por: Fazary, Ahmed E., et al.
Publicado: (2021) -
XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway
por: Li, Chong, et al.
Publicado: (2018) -
Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2020) -
Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
por: Shetti, Dattatrya, et al.
Publicado: (2019) -
XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines
por: Renna, Cristiano, et al.
Publicado: (2015)